Demographical and serological details of healthy blood donors and dengue patients used in the study.

Demographical and serological details of healthy blood donors and dengue patients used in the study.

<p>Demographical and serological details of healthy blood donors and dengue patients used in the study.</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Shweta Chelluboina (22145802) (author)
Beste egile batzuk:	Darshan Kshirsagar (22145805) (author), Gauri Panzade (22145808) (author), Akhilesh Chandra Mishra (4875961) (author), Vidya Arankalle (7482945) (author), Shubham Shrivastava (408570) (author)
Argitaratua:	2025
Gaiak:	Microbiology Cell Biology Molecular Biology Neuroscience Biotechnology Immunology Cancer Mental Health Hematology Infectious Diseases Virology three cell lines healthy blood donors fc &# 947 existing igg antibodies measuring neutralizing antibodies 12 blood donors dengue virus antibodies significantly lower denv reduction neutralization test 4 serotypes suggest xlink "> pre neutralizing antibodies xlink "> dengue virus dengue igg 4 serotypes significantly higher neutralization titres findings suggest &# 8217 neutralizing concentrations 4 titres standardized system low levels individuals exposed enhancing activity enhancing activities denv ). 4 infection
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak

A line graph of log<sub>10</sub> FRNT<sub>50</sub> titres of 12 healthy blood donor samples (9 dengue IgG-positive and 3 dengue IgG-negative samples) for (A) DENV-2 and (B) DENV-4 in Vero and Vero-CD32a cells.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

Scatter plot of log<sub>10</sub> FRNT<sub>50</sub> titres of 21 samples (9 healthy blood donors and 12 secondary dengue patients) for (A & B) DENV-2 and (C & D) DENV-4 in Vero and Vero-CD32a cells, respectively.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

A scatter plot of log<sub>10</sub> virus titers (ffu/ml) at different dilutions (1:20 to 1:20,000) of 12 secondary dengue patient samples.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

A scatter plot of log<sub>10</sub> virus titers (ffu/ml) at different dilutions (1:20 to 1:20,000) of 12 healthy donor plasma samples.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

Dilution-dependent correlation of binding (ELISA), neutralizing antibody positivity (FRNT), and fold-enhancement of serotype-specific DENV infection.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

Replication kinetics of DENV-2 & DENV-4 in Vero and Vero-CD32a cell lines.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

A plot of average foci counts across concentrations of HB112 at different MOIs of DENV-2 and DENV-4 virus in both U937 and K562 cells.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

(A) Comparison of infection enhancement patterns from supernatants collected from the wells incubating mixtures of different concentrations of HB112 antibody with DENV-2 virus.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

(A) Representative flow cytometry plots showing the percentage of CD32a+ cells in K562, U937, Vero-CD32a, and Vero CCL-81 cells.
nork: Shweta Chelluboina (22145802)
Argitaratua: (2025)

Serum dilution at peak fold enhancement of DENV2.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

DENV2 binding reactivity and functional antibody responses.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Antibody response to IMOJEV vaccination.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Baseline IgG binding to DENV2 and JEV VLP.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Test of different JEV antigen concentrations for selected serum samples at 1:200 serum dilution.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Master table of ELISA, neutralization and enhancement assay results.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Correlation between (A) DENV2 or (B) JEV ELISA P/N values with neutralization titers.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Comparison of vaccine response based on pre-IMOJEV vaccination DENV2 functional antibody response.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Pre- and post-IMOJEV vaccination DENV2 antibody dependent enhancement of selected samples.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Pre- and post-IMOJEV vaccination anti-DENV2 neutralizing titers.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Correlation between DENV2 ELISA P/N Values and DENV 1, 3 and 4 ELISA P/N Values.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Relationship between the log<sub>10</sub> JEV RVPNT50 titers and (A) age or (B) DENV2 binding reactivities (two-tailed Spearman rank correlation test).
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Pre- and post- IMOJEV vaccination anti-JEV neutralizing titers.
nork: Fatima Ericka S. Vista (22290913)
Argitaratua: (2025)

Table 1_Protection against lethal HAdV-4 challenge in STAT1 mice by novel human monoclonal antibodies.docx
nork: Xinyi Zhang (36040)
Argitaratua: (2025)

Prevalence of Dengue serotypes, Chikungunya, and Dengue-Chikungunya co-infections across age, sex, and symptoms.
nork: Mansi Rajendra Malik (22032949)
Argitaratua: (2025)

Lower levels of anti-AeD7L1 + 2 IgG are associated with more DENV seroconversions in enrolled households.
nork: Lauren E. Bahr (16892347)
Argitaratua: (2025)

Anti-AeD7L1 + 2 IgG levels correlate with age and season, but not entomological surveillance data, in an endemically exposed population.
nork: Lauren E. Bahr (16892347)
Argitaratua: (2025)

Anti-AeD7L1 + 2 antibodies are not robust markers of acute <i>Aedes</i> exposure.
nork: Lauren E. Bahr (16892347)
Argitaratua: (2025)

Anti-AeD7L1 + 2 IgG is more a more sensitive measure than anti-AeD7L1 + 2 IgM in both limited and chronic <i>Aedes</i> exposure scenarios.
nork: Lauren E. Bahr (16892347)
Argitaratua: (2025)

Supporting data for study.
nork: Lauren E. Bahr (16892347)
Argitaratua: (2025)

Summary of all samples with details on Gender, age, and screening data for Dengue, Chikungunya using NS1 ELISA, IgM ELISA, and Dengue serotypes, with q RT-PCR (DENCHIK) respectively.
nork: Mansi Rajendra Malik (22032949)
Argitaratua: (2025)

Comparison of prevalence of Dengue, Chikungunya, and Co-infection through ELISA and DENCHIK assay.
nork: Mansi Rajendra Malik (22032949)
Argitaratua: (2025)

Interactive models of detection methods for Dengue (NS1 antigen, qRTPCR) and Chikungunya (IgM and qRTPCR) by sampling months.
nork: Mansi Rajendra Malik (22032949)
Argitaratua: (2025)

Data Sheet 1_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)

Data Sheet 4_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)

Data Sheet 3_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)

Data Sheet 2_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)

Data Sheet 6_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)

Data Sheet 5_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)

Data Sheet 9_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)

Data Sheet 8_Applications and insights from continuous dengue virus infection in a stable cell line.pdf
nork: M. Jane Morwitzer (21590837)
Argitaratua: (2025)